Variant report
Variant | nsv1042966 |
---|---|
Chromosome Location | chr12:30420183-30439329 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000257456 | chromatin interactions |
ENSG00000133687 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs182437144 | chr12:30420844-30420845 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs386761618 | chr12:30420850-30420851 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs112007812 | chr12:30420851-30420852 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs7974311 | chr12:30420852-30420853 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs571978028 | chr12:30420866-30420867 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs7974324 | chr12:30420887-30420888 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs578071035 | chr12:30420901-30420902 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs374429519 | chr12:30420917-30420918 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs186617812 | chr12:30420966-30420967 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs368898598 | chr12:30420995-30420996 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs553227197 | chr12:30421002-30421003 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs190734942 | chr12:30421038-30421039 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs533566658 | chr12:30421051-30421052 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs76722752 | chr12:30421071-30421072 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs551962034 | chr12:30421106-30421107 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs545069178 | chr12:30421115-30421116 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs143750179 | chr12:30421117-30421118 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs549136671 | chr12:30421136-30421137 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs7956322 | chr12:30421161-30421162 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs538001925 | chr12:30421170-30421171 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs572431049 | chr12:30421194-30421195 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs543233829 | chr12:30421217-30421218 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs181196218 | chr12:30421264-30421265 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs16906003 | chr12:30421268-30421269 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs577964245 | chr12:30421288-30421289 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs185850181 | chr12:30421307-30421308 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs374800092 | chr12:30421308-30421309 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs71049446 | chr12:30421336-30421337 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs536127889 | chr12:30421392-30421393 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs372867729 | chr12:30421447-30421448 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs189828260 | chr12:30421455-30421456 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs11050776 | chr12:30421463-30421464 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs141255363 | chr12:30421472-30421473 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs150654078 | chr12:30421487-30421488 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs545331358 | chr12:30421488-30421489 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs113531806 | chr12:30421514-30421515 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs528024646 | chr12:30421553-30421554 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs531751188 | chr12:30421563-30421564 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs561378219 | chr12:30421587-30421588 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs139780452 | chr12:30421607-30421608 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs563438507 | chr12:30421610-30421611 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs143652038 | chr12:30421620-30421621 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs146307654 | chr12:30421627-30421628 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs139486725 | chr12:30421635-30421636 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs11050777 | chr12:30421660-30421661 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
46 | rs565531396 | chr12:30421748-30421749 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs10843690 | chr12:30421778-30421779 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs540969973 | chr12:30421868-30421869 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs144543294 | chr12:30421872-30421873 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs182353394 | chr12:30421934-30421935 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Wilms tumour | 21544195 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Testicular cancer | 18059402 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Seminomas | 18059402 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 21858162 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 20164919 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Breast cancer | 21509527 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Breast cancer | 17133270 | CNVD |
Cancer | 21129771 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17899364 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:30420800-30421200 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
2 | chr12:30420800-30421800 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
3 | chr12:30420800-30421800 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
4 | chr12:30421200-30422000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
5 | chr12:30421200-30422800 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
6 | chr12:30421800-30423800 | Enhancers | Fetal Stomach | stomach |
7 | chr12:30421800-30424200 | Enhancers | Fetal Lung | lung |
8 | chr12:30422800-30423000 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
9 | chr12:30423000-30423400 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
10 | chr12:30423200-30423800 | Enhancers | Stomach Smooth Muscle | stomach |
11 | chr12:30423400-30424000 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
12 | chr12:30424800-30430000 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
13 | chr12:30429000-30429800 | Enhancers | Liver | Liver |
14 | chr12:30429400-30429600 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
15 | chr12:30429600-30430600 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
16 | chr12:30429800-30431400 | Weak transcription | Liver | Liver |
17 | chr12:30430600-30432000 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
18 | chr12:30431400-30433400 | Enhancers | Liver | Liver |